Stuart Naylor
Known title: CHIEF SCI OFCR, OPHTHALMOLOGYCIK: 0001742771
Associated companies
Transaction History
| MGTX | ▼ Sell | Open Market | 27,659 | $294K | 10/6/2026 | View on chart |
| MGTX | ▼ Sell | Open Market | 2,547 | $35K | 7/7/2026 | View on chart |
| MGTX | ▼ Sell | Open Market | 25,112 | $374K | 7/7/2026 | View on chart |
| MGTX | ▼ Sell | Open Market | 27,661 | $259K | 4/7/2026 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 25,000 | — | 2/21/2026 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 11,750 | $88K | 2/21/2026 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 75,000 | — | 1/17/2026 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 35,250 | $262K | 1/17/2026 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 37,500 | — | 1/7/2026 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 17,625 | $136K | 1/7/2026 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 50,000 | — | 2/21/2025 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 23,500 | $172K | 2/21/2025 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 23,750 | — | 1/14/2025 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 11,163 | $64K | 1/14/2025 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 37,500 | — | 1/7/2025 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 17,625 | $112K | 1/7/2025 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 11,163 | $71K | 1/14/2024 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 23,750 | — | 1/14/2024 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 40,000 | — | 1/8/2024 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 18,800 | $125K | 1/8/2024 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 75,000 | — | 1/7/2024 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 35,250 | $222K | 1/7/2024 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 47,500 | — | 1/14/2023 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 22,325 | $156K | 1/14/2023 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 18,800 | $124K | 1/8/2023 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 40,000 | — | 1/8/2023 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 37,600 | $810K | 1/8/2022 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 80,000 | — | 1/8/2022 | View on chart |
| MGTX | ▼ Sell | Open Market | 12,000 | $215K | 10/18/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Goldman Sachs initiates MeiraGTx coverage with Neutral rating
Goldman Sachs has started covering MeiraGTx, assigning a Neutral rating and a price target of $16. This new analyst view comes as the company also appointed Alan M. Sebulsky to its board of directors. The stock is currently trading near its 52-week low, providing context for the firm's initial assessment.
Goldman Sachs initiates MeiraGTx coverage with Neutral rating. Goldman Sachs has started covering MeiraGTx, assigning a Neutral rating and a price target of $16. This new analyst view comes as the company also appointed Alan M. Sebulsky to its board of directors. The stock is currently trading near its 52-week low, providing context for the firm's initial assessment.